2007

1. A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia

   European Neuropsychopharmacology, Vol. 17, Núm. 6-7, pp. 456-463